179 related articles for article (PubMed ID: 38355988)
1. Catalyst-free late-stage functionalization to assemble α-acyloxyenamide electrophiles for selectively profiling conserved lysine residues.
Zhao Y; Duan K; Fan Y; Li S; Huang L; Tu Z; Sun H; Cook GM; Yang J; Sun P; Tan Y; Ding K; Li Z
Commun Chem; 2024 Feb; 7(1):31. PubMed ID: 38355988
[TBL] [Abstract][Full Text] [Related]
2. Ynamide Electrophile for the Profiling of Ligandable Carboxyl Residues in Live Cells and the Development of New Covalent Inhibitors.
Li S; Zhang P; Xu F; Hu S; Liu J; Tan Y; Tu Z; Sun H; Zhang ZM; He QY; Sun P; Ding K; Li Z
J Med Chem; 2022 Aug; 65(15):10408-10418. PubMed ID: 35880853
[TBL] [Abstract][Full Text] [Related]
3. Cell-active, irreversible covalent inhibitors that selectively target the catalytic lysine of EGFR by using fluorosulfate-based SuFEx chemistry.
Tang G; Wang W; Wang X; Ding K; Ngan SC; Chen JY; Sze SK; Gao L; Yuan P; Lu X; Yao SQ
Eur J Med Chem; 2023 Nov; 259():115671. PubMed ID: 37499291
[TBL] [Abstract][Full Text] [Related]
4. Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development.
Tang G; Wang W; Zhu C; Huang H; Chen P; Wang X; Xu M; Sun J; Zhang CJ; Xiao Q; Gao L; Zhang ZM; Yao SQ
Angew Chem Int Ed Engl; 2024 Mar; 63(12):e202316394. PubMed ID: 38248139
[TBL] [Abstract][Full Text] [Related]
5. Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine.
Tang KC; Cao J; Boatner LM; Li L; Farhi J; Houk KN; Spangle J; Backus KM; Raj M
Angew Chem Int Ed Engl; 2022 Jan; 61(5):e202112107. PubMed ID: 34762358
[TBL] [Abstract][Full Text] [Related]
6. Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition.
Dalton SE; Dittus L; Thomas DA; Convery MA; Nunes J; Bush JT; Evans JP; Werner T; Bantscheff M; Murphy JA; Campos S
J Am Chem Soc; 2018 Jan; 140(3):932-939. PubMed ID: 29232121
[TBL] [Abstract][Full Text] [Related]
7. Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*.
Quach D; Tang G; Anantharajan J; Baburajendran N; Poulsen A; Wee JLK; Retna P; Li R; Liu B; Tee DHY; Kwek PZ; Joy JK; Yang WQ; Zhang CJ; Foo K; Keller TH; Yao SQ
Angew Chem Int Ed Engl; 2021 Jul; 60(31):17131-17137. PubMed ID: 34008286
[TBL] [Abstract][Full Text] [Related]
8. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
Li J; Wang G; Ye M; Qin H
Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
[TBL] [Abstract][Full Text] [Related]
9. Peptide-Based Covalent Inhibitors Bearing Mild Electrophiles to Target a Conserved His Residue of the Bacterial Sliding Clamp.
Compain G; Monsarrat C; Blagojevic J; Brillet K; Dumas P; Hammann P; Kuhn L; Martiel I; Engilberge S; Oliéric V; Wolff P; Burnouf DY; Wagner J; Guichard G
JACS Au; 2024 Feb; 4(2):432-440. PubMed ID: 38425897
[TBL] [Abstract][Full Text] [Related]
10. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.
Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC
ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490
[TBL] [Abstract][Full Text] [Related]
11. ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries.
Jiang L; Liu S; Jia X; Gong Q; Wen X; Lu W; Yang J; Wu X; Wang X; Suo Y; Li Y; Uesugi M; Qu ZB; Tan M; Lu X; Zhou L
J Am Chem Soc; 2023 Nov; 145(46):25283-25292. PubMed ID: 37857329
[TBL] [Abstract][Full Text] [Related]
12. A targeted covalent inhibitor of p97 with proteome-wide selectivity.
Ye Z; Wang K; Chen L; Jin X; Chen H; Tang G; Yao SQ; Feng Z; Zhang CJ
Acta Pharm Sin B; 2022 Feb; 12(2):982-989. PubMed ID: 35256959
[TBL] [Abstract][Full Text] [Related]
13. Lysine-Reactive
Kawano M; Murakawa S; Higashiguchi K; Matsuda K; Tamura T; Hamachi I
J Am Chem Soc; 2023 Dec; 145(48):26202-26212. PubMed ID: 37987622
[TBL] [Abstract][Full Text] [Related]
14. Covalent Inhibition by a Natural Product-Inspired Latent Electrophile.
Byun DP; Ritchie J; Jung Y; Holewinski R; Kim HR; Tagirasa R; Ivanic J; Weekley CM; Parker MW; Andresson T; Yoo E
J Am Chem Soc; 2023 May; 145(20):11097-11109. PubMed ID: 37183434
[TBL] [Abstract][Full Text] [Related]
15. A proteome-wide atlas of lysine-reactive chemistry.
Abbasov ME; Kavanagh ME; Ichu TA; Lazear MR; Tao Y; Crowley VM; Am Ende CW; Hacker SM; Ho J; Dix MM; Suciu R; Hayward MM; Kiessling LL; Cravatt BF
Nat Chem; 2021 Nov; 13(11):1081-1092. PubMed ID: 34504315
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
17. Chemical proteomic identification of functional cysteines with atypical electrophile reactivities.
Litwin K; Crowley VM; Suciu RM; Boger DL; Cravatt BF
Tetrahedron Lett; 2021 Mar; 67():. PubMed ID: 33776155
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Covalent Modification of K-Ras(G12D) and K-Ras(G12C) with Tunable Oxirane Electrophiles.
Yu Z; He X; Wang R; Xu X; Zhang Z; Ding K; Zhang ZM; Tan Y; Li Z
J Am Chem Soc; 2023 Sep; 145(37):20403-20411. PubMed ID: 37534597
[TBL] [Abstract][Full Text] [Related]
19. Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs).
Roskoski R
Pharmacol Res; 2021 Mar; 165():105422. PubMed ID: 33434619
[TBL] [Abstract][Full Text] [Related]
20. A simple method for developing lysine targeted covalent protein reagents.
Gabizon R; Tivon B; Reddi RN; van den Oetelaar MCM; Amartely H; Cossar PJ; Ottmann C; London N
Nat Commun; 2023 Dec; 14(1):7933. PubMed ID: 38040731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
